These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26928207)

  • 1. Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers.
    Jia FF; Tan ZR; McLeod HL; Chen Y; Ou-Yang DS; Zhou HH
    Xenobiotica; 2016 Oct; 46(10):896-900. PubMed ID: 26928207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
    Nicolau DP; Sutherland CA; Arguedas A; Dagan R; Pichichero ME
    Paediatr Drugs; 2007; 9(2):119-23. PubMed ID: 17407367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
    Lode H; Müller C; Borner K; Nord CE; Koeppe P
    Antimicrob Agents Chemother; 1992 Jan; 36(1):144-9. PubMed ID: 1590680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of time of administration and posture on the pharmacokinetics of cefprozil.
    Shyu WC; Gleason CR; Barbhaiya RH
    Clin Pharmacokinet; 1993 Sep; 25(3):237-42. PubMed ID: 8222462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
    Shukla UA; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Aug; 32(8):725-31. PubMed ID: 1487562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1210-3. PubMed ID: 2393283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study.
    Fujita T; Nakamura K; Yamazaki A; Ozaki M; Sahashi K; Shichijo K; Nomura K; Maeda M; Nakamura T; Fujita T; Yokota S; Kuroyama S; Kumagai Y; Majima M; Ohtani Y
    J Clin Pharm Ther; 2007 Jun; 32(3):277-85. PubMed ID: 17489880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of multiple-dose cefprozil and comparison with cefaclor.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Martin RR; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1198-203. PubMed ID: 2393281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of pharmacokinetic interaction of paroxetine and roxithromycin on bencycloquidium bromide in healthy subjects.
    Agbokponto JE; Luo Z; Liu R; Liu Z; Liang M; Ding L
    Eur J Pharm Sci; 2015 Mar; 69():37-43. PubMed ID: 25559065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans.
    Shyu WC; Shah VR; Campbell DA; Wilber RB; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Sep; 32(9):798-803. PubMed ID: 1430299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and pharmacokinetics of cefprozil.
    Barriere SL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S184-8; discussion S195-6. PubMed ID: 1617036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of subcutaneous versus intramuscular administration of ceftiofur crystalline-free acid to bearded dragons (Pogona vitticeps).
    Churgin SM; Musgrave KE; Cox SK; Sladky KK
    Am J Vet Res; 2014 May; 75(5):453-9. PubMed ID: 24762017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of cefprozil into human breast milk.
    Shyu WC; Shah VR; Campbell DA; Venitz J; Jaganathan V; Pittman KA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 May; 36(5):938-41. PubMed ID: 1510416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    McCarty JM; Pierce PF
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefprozil in the treatment of chronic maxillary sinusitis. Clinical and microbiological effectiveness and penetration into sinuses examination].
    Orendorz-Fraczkowska K; Bochnia M; Dziewiszek W; Stankiewicz M; Smutnicka D
    Otolaryngol Pol; 2005; 59(4):517-22. PubMed ID: 16273854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.
    Kaucher KA; Acquisto NM; Rao GG; Kaufman DC; Huntress JD; Forrest A; Haas CE
    Pharmacotherapy; 2015 May; 35(5):482-8. PubMed ID: 26011141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.